Stock Taper 
BLUE OWL CAPITAL HOLDINGS LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Conduent Incorporated | CNDT | 5.04M | $7.35M |
 Aktis Oncology, Inc. | AKTS | 3.07M | $98.95M |
 Nuveen Churchill Direct Lending Corp. | NCDL | 2.14M | $26.62M |
 Blue Owl Capital Corporation | OBDC | 2.05M | $22.23M |
 Cullinan Therapeutics, Inc. | CGEM | 1.54M | $28.04M |
 Space Exploration Technologies Corp. | SPCX | 1.4M | $239M |
 Aquestive Therapeutics, Inc. | AQST | 942.93K | $3.92M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 762.59K | $10.91M |
 LENZ Therapeutics, Inc. | LENZ | 756.72K | $4.3M |
 MapLight Therapeutics, Inc. | MPLT | 729.93K | $26.16M |
 Corvus Pharmaceuticals, Inc. | CRVS | 608.6K | $9.09M |
 Eledon Pharmaceuticals, Inc. | ELDN | 566.51K | $2.23M |
 Marker Therapeutics, Inc. | MRKR | 554.25K | $814.75K |
 COMPASS Pathways plc | CMPS | 450K | $6.37M |
 ORIC Pharmaceuticals, Inc. | ORIC | 400K | $4.33M |
 Viridian Therapeutics, Inc. | VRDN | 260K | $4.78M |
 Starwood Property Trust, Inc. | STWD | 196.35K | $3.22M |
 Ultragenyx Pharmaceutical Inc. | RARE | 182.64K | $6.1M |
 Capital One Financial Corporation | COF | 119.76K | $24.03M |
 Chime Financial, Inc. Class A Common Stock | CHYM | 89.88K | $1.84M |